Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today a ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback